Global Gastrointestinal Therapeutics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Gastrointestinal Therapeutics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global gastrointestinal therapeutics market report has been segmented on the basis of route, application, distribution channel, and region.
Global Gastrointestinal Therapeutics Market: Overview
Gastrointestinal therapeutics are used for their effects on the gastrointestinal system such as improving digestion, regulate mobility and water flow in order to regulate the gastrointestinal system, and controlling gastric acidity. Gastrointestinal tract also known as the digestive tract is an organ system present within animal and humans that takes food and work on its digestion procedure. It helps to absorb energy and nutrients and removes the remaining waste in the form of feces.
Global Gastrointestinal Therapeutics Market: Dynamics
Growing prevalence of gastrointestinal diseases among individuals is a key factor driving growth of the global gastrointestinal therapeutics market. In addition, increasing adoption of the biologic drug for the treatment of gastrointestinal diseases is another factor supporting growth of the global market. Furthermore, growing awareness regarding gastrointestinal drugs and expanding the accessibility of treatment are also factors expected to boost growth of the global gastrointestinal therapeutics market in the near future.
However, there is no permanent cure for irritable bowel syndrome and inflammatory bowel disease as their cause is unknown. This factor could affect growth of the global gastrointestinal therapeutics market. Nevertheless, growing investment for the development of new products and improvement in supply chain management can create high revenue opportunities for players in the target market.
Global Gastrointestinal Therapeutics Market: Segment Analysis
Among the route segments, the intravenous segment dominates the global market in terms of revenue and anticipated to maintain its position in the near future. Cost of intravenous drugs is higher than oral drugs. The oral segment accounted for second-highest share in terms of revenue. Intravenous drugs are more convenient in younger patients is a factor supporting growth of this segment in the target market.
Among the application segments, the ulcerative colitis segment is expected to register lucrative growth in terms of revenue over the forecast period. Increasing prevalence of ulcerative colitis, owing to the consumption of unhealthy food and poor prognosis that can result in high probability of occurrence of this condition is a factor anticipated to support this segment in the global market.
Global Gastrointestinal Therapeutics Market: Regional Analysis
Market in North America accounted for major share in terms of revenue and is expected to maintain its dominance over the forecast period. Increasing number of incidences of gastrointestinal diseases among individuals, owing to changing lifestyle is a factor fueling growth of the target market in this region. In addition, government initiatives to prevent gastrointestinal diseases is another factor driving growth of the gastronomical therapeutics market in North America.
Market in Asia Pacific is anticipated to register high growth in terms of revenue in the near future. Increasing rates of gastronomical diseases among individuals is a factor propelling growth of the target market in this region. Additionally, increasing investment in the healthcare sector, as well as upgradation of current healthcare infrastructure, are also factors expected to augment growth of the gastronomical therapeutics market in countries in the Asia Pacific.
Global Gastrointestinal Therapeutics Market Segmentation:
Segmentation by Route:
Segmentation by Application:
- Crohn’s Disease
- Ulcerative Colitis
Segmentation by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Takeda Pharmaceutical Company Limited
- Valeant Pharmaceuticals International company
- Allergan plc
- Bayer AG
- Abbott Laboratories
- AstraZeneca PLC
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
- Janssen Biotech, Inc.
- Sanofi company
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!